Ask AI
Antivirals for Refractory CMV
Charting the Course Podcast: Antivirals for Refractory CMV Infections

Released: August 29, 2025

Activity

Progress
1
Course Completed

Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:

  • Comparisons of available CMV antiviral therapies:
    • Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavir
  • Considerations for renal function monitoring with ganciclovir and valganciclovir
  • A treatment algorithm for relapsed/refractory CMV
  • The latest clinical trial data and guideline recommendations